Literature DB >> 13585079

Third international standard for posterior pituitary; re-named third international standard for oxytocic, vasopressor and antidiuretic substances in 1956.

D R BANGHAM, M V MUSSETT.   

Abstract

In October 1955, stocks of the Second International Standard for Posterior Pituitary were running low and the Department of Biological Standards of the National Institute for Medical Research, London, was asked to proceed with the arrangements for an international collaborative assay of material for the Third Standard. A single 142-g batch of posterior-pituitary-lobe powder was obtained and distributed in ampoules, in approximately 30-mg quantities. Samples were sent to 19 laboratories in 10 countries. In all, 185 assays were carried out, 122 for oxytocic activity, 53 for vasopressor activity and 10 for antidiuretic activity.On the basis of the results, which were analysed statistically at the National Institute for Medical Research, it was agreed that the potency of the Third Standard (re-named International Standard for Oxytocic, Vasopressor and Antidiuretic Substances in 1956, in view of the recent synthesis of oxytocin and vasopressin) should be expressed as 2.0 International Units per milligram. The International Unit therefore remains unchanged as 0.5 mg of the dry powder.

Entities:  

Keywords:  PITUITARY GLAND, POSTERIOR/hormones

Mesh:

Substances:

Year:  1958        PMID: 13585079      PMCID: PMC2537666     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  The oxytocic and pressor activities of the U.S.P. Posterior Pituitary Reference Standard.

Authors:  A T NIELSEN; C HAMBURGER
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1956

2.  A method for the assay of very small amounts of antidiuretic activity with a note on the antidiuretic titre of rat's blood.

Authors:  S E DICKER
Journal:  J Physiol       Date:  1953-10       Impact factor: 5.182

3.  [Purification of the hormones of the posterior lobe of the pituitary gland of cattle. II. Vasopressin].

Authors:  P FROMAGEOT; R ACHER; H CLAUSER; H MAIER-HUSER
Journal:  Biochim Biophys Acta       Date:  1953-11

4.  The antidiuretic assay of vasopressin by intravenous injection into unanaesthetized rats.

Authors:  M GINSBURG; H HELLER
Journal:  J Endocrinol       Date:  1953-07       Impact factor: 4.286

5.  The quantitative assay of vasopressin.

Authors:  J DEKANSKI
Journal:  Br J Pharmacol Chemother       Date:  1952-12

6.  Oxytocic activity of purified vasopressin.

Authors:  E A POPENOE; J G PIERCE; V DU VIGNEAUD; H B VAN DYKE
Journal:  Proc Soc Exp Biol Med       Date:  1952-11

7.  The bioassay of pitressin and antidiuretic substances in blood and urine.

Authors:  M STEIN; R JINKS; I A MIRSKY
Journal:  Endocrinology       Date:  1952-12       Impact factor: 4.736

8.  A modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract.

Authors:  P HOLTON
Journal:  Br J Pharmacol Chemother       Date:  1948-12

9.  Preparation of high potency oxytocic material by the use of counter-current distribution.

Authors:  A H LIVERMORE; V DU VIGNEAUD
Journal:  J Biol Chem       Date:  1949-08       Impact factor: 5.157

10.  International standard for erythromycin.

Authors:  J H HUMPHREY; J W LIGHTBOWN; M V MUSSETT
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

  10 in total
  36 in total

1.  (DESAMINO-ARGININE-VASOPRESSIN, AN ANALOGUE OF ARGININE-VASOPRESSIN WITH HIGH ANTIDIURETIC ACTIVITY.)

Authors:  R L HUGUENIN; E STUERMER; R A BOISSONNAS; B BERDE
Journal:  Experientia       Date:  1965-02-15

2.  The synthesis and some pharmacological effects of serine-isoleucine-oxytocin, a probable neurohypophysial hormone.

Authors:  S GUTTMANN; B BERDE; E STURMER
Journal:  Experientia       Date:  1962-10-15

3.  The biological activities of arginine-vasotocin obtained by a new synthesis.

Authors:  B BERDE; R HUGUENIN; E STURMER
Journal:  Experientia       Date:  1962-10-15

4.  Hypothalamic neurohumors in the control of the functions of the anterior hypophysis.

Authors:  R GUILLEMIN
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963

5.  Renal excretion of hyaluronidase and calcium in man during the antidiuretic action of vasopressins and some analogues.

Authors:  S E DICKER; M G EGGLETON
Journal:  J Physiol       Date:  1961-07       Impact factor: 5.182

6.  Isolation and protein composition of membranes of neurosecretory vesicles and plasma membranes from the neural lobe of the bovine pituitary gland.

Authors:  H Vilhardt; R V Baker; D B Hope
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

7.  The composition of crystalline complexes of neurophysin-M with [8-arginine]-vasopressin and oxytocin.

Authors:  M D Hollenberg; D B Hope
Journal:  Biochem J       Date:  1967-12       Impact factor: 3.857

8.  Vasopressin release by nicotine: the site of action.

Authors:  W Feldberg; P G Guertzenstein; M Rocha e Silva
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

9.  Studies on the chemical modification of the tyrosine residue in bovine neurophysin-II.

Authors:  A J Furth; D B Hope
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

10.  Plasma vasopressin levels during hypoxaemia and the cardiovascular effects of exogenous vasopressin in foetal and adult sheep.

Authors:  D W Rurak
Journal:  J Physiol       Date:  1978-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.